Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering, investors were not thrilled about this quarter for these two pharmaceutical giants.
SmileDirectClub shares pushed higher on Tuesday after the company announced that it had received a patent for its new retail plan.
iBio has provided an update on its COVID-19 vaccine manufacturing capacity and said that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals.
Micron Technology stock has made a solid recovery from its lows, and with semiconductors considered a leading indicator, it could signal a larger recovery for the markets in general.
A combination of financial factors creates an interesting value proposition for investors as Altria reports later this week. Also, we will get a chance to see if anything happens with the dividend.
Shifting business models for Lyft and its main rival will be huge going forward. Lyft shares are signaling a recovery, though it still could be a bumpy ride back to normalcy.
Alphabet is scheduled to release its most recent quarterly results after the markets close on Tuesday, and analysts are looking for solid year-over-year growth.
Starbucks is set to report its most recent quarterly results after the closing bell on Tuesday. The company recently announced a partnership with Beyond Meat.
PepsiCo released better than expected first-quarter financial results before the markets opened on Tuesday.
3M released better than expected first-quarter financial results but withdrew its full-year guidance before the markets opened on Thursday.
Caterpillar reported mixed first-quarter quarterly results and withdrew its guidance before the markets opened on Tuesday.
3M is scheduled to report its most recent quarterly results before the markets open on Tuesday for a period in which it became a major player in the fight against the coronavirus.
Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.
Amazon.com, a big beneficiary of the coronavirus outbreak, is set to release its first-quarter financial results later this week. Analysts are offering their two cents before the report comes out.
As there is currently no FDA-approved treatment for Alzheimer’s agitation, any progress here could be lucrative. Axsome Therapeutics has announced a big step forward in its midstage Alzheimer’s study
Caterpillar is scheduled to release its most recent quarterly results before the opening bell on Tuesday. Overall, expectations are muted.
Zynga and Amazon.com are partnering to bring free content to Amazon Prime members with one of Zynga’s major franchises.
Aytu BioScience shares made an incredible gain to start the week following the firm’s announcement in regards to a coronavirus treatment.
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The April 15 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
